PGA resoquick™

multifilament, short-term absorbable

PGA resoquick™ is a polymer of glycolic acid. The linear, high molecular weight polyglycolic acid is synthesised in the presence of a catalyst via the intermediary product glycolide, a cyclic ester via an intermediary product, glycolide.

• needle-thread-combination
• precut lengths

USP 6-0 to 2 (0.7-5 metric)


polyglycolic acid

Metabolisation of the PGA suture within the tissue occurs by the uptake of water, thus reversing the synthesis. The monomeric glycolic acid is split enzymatically into CO2 and H2O by the normal metabolism.

Suture material containing 10% lactide as copolymerisate differs only slightly in its physical and physiological
properties from pure PGA sutures. The fine, precision-braided filaments guarantee a very high tensile strength as well as great suppleness. The special resolactone coating thinly covers the fibre bundles for specific reduction of surface friction.

PGA resoquick™ is indicated for use in general soft tissue approximation, including ophthalmic (e.g. conjunctiva)
procedures, but not in cardiovascular or neurological procedures.

Absorbable suture approximates the tissue during the healing phase and progressively loses its tensile strength and breaking load. After only seven days PGA resoquick™ has already lost 50% of its original breaking load. After 14 days the breaking load is lost completely.


  • very supple
  • high tensile strength
  • minimal tissue reaction
  • smooth passage through tissue
  • high knot security



View all Resorba® videos, factsheets and resources:

PGA resoquick™
Factsheet (PDF – 150Kb)

Resorba is a registered trademark of RESORBA Medical GmbH. All rights reserved

Resorba is a registered trademark of
RESORBA Medical GmbH.
All rights reserved

Copyright © RESORBA Medical GmbH 2020 | Design by Lumisi